Kreitman, Robert
- Division of Basic Sciences - Nci (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #4,309
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
NIH Funding · FY2023
Linked Award Amount
$1.9M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#4,309
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Kreitman, Robert as a PI. Multi-PI records show the full award amount for context.
- 1ZIABC010301-26ZIAContact PIDevelopment of Recombinant Toxins to Treat Hematologic Malignancies$1.7Maward amount
- 1ZIABC011952-04ZIAContact PIPatterns of immune response in COVID-19 patients$185.1Kaward amount
Award organization
Organizations that administered FY2023 awards listing Kreitman, Robert as a PI.
FY2023 award administered by Division of Basic Sciences - Nci ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardDivision of Basic Sciences - Nci
- 2007$500K Cumulative Funding
- 2007Entered Top 50% NationallyRanked #9255
- 2008$1M Cumulative Funding
- 2009$2M Cumulative Funding
- 2013$5M Cumulative Funding
- 2016Entered Top 25% NationallyRanked #4925
- 2017$10M Cumulative Funding